Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial
Abstract Objective The delivery of healthcare at home has expanded to intravenous infusions of monoclonal antibodies. A recently developed model of care for home infusions of natalizumab for people with relapsing‐remitting multiple sclerosis was evaluated. This pilot study of home infusions of natal...
Main Authors: | Timothy J. Schultz, Anne Thomas, Paul Georgiou, Mahasen S. Juaton, Lynette Cusack, Lorraine Simon, Kerisha Naidoo, Kevin Webb, Jonathan Karnon, Janakan Ravindran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51410 |
Similar Items
-
Piloting home infusions of Tysabri (natalizumab): a randomised crossover trial
by: Tim Schultz, et al.
Published: (2019-08-01) -
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
by: Gatzonis Stylianos, et al.
Published: (2009-08-01) -
The use of natalizumab for multiple sclerosis
by: Brandstadter R, et al.
Published: (2017-06-01) -
Natalizumab treatment for multiple sclerosis
by: Maria Lucia Brito Ferreira
Published: (2014-12-01) -
Review: Natalizumab in the treatment of multiple sclerosis
by: Özgür Yaldizli, et al.
Published: (2009-03-01)